Clinical Trial Update: Aripiprazole for the Augmentation of Antidepressant Therapy [Phase 4]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase 4 trial evaluating aripiprazole as augmentation to antidepressant therapy for Major Depressive Diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Taiwan Otsuka Pharm. Co., Ltd | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED